Risk of acute liver injury associated with the use of drugs: a multicentre population survey - PubMed (original) (raw)
Multicenter Study
. 2007 Jun 15;25(12):1401-9.
doi: 10.1111/j.1365-2036.2007.03338.x.
L Ibáñez, E Pérez, X Vidal, M Buti, X Xiol, A Mas, C Guarner, M Forné, R Solà, J Castellote, J Rigau, J-R Laporte
Affiliations
- PMID: 17539979
- DOI: 10.1111/j.1365-2036.2007.03338.x
Free article
Multicenter Study
Risk of acute liver injury associated with the use of drugs: a multicentre population survey
M Sabaté et al. Aliment Pharmacol Ther. 2007.
Free article
Abstract
Background: Acute liver injury of uncertain aetiology is often drug related and quantitative information about the associated risk is scarce.
Aim: To estimate the risk of acute liver injury associated with the use of drugs.
Methods: In a population survey study, 126 cases of acute liver injury were prospectively assembled from January 1993 to December 1999, in patients over 15 years of age, in 12 hospitals in Barcelona (Spain). We estimated the relative risk for each drug as the ratio between the incidence of acute liver injury among the exposed population to the drug and the incidence of acute liver injury among those not exposed to it. Drug consumption data were used to estimate the exposed population.
Results: Isoniazid, pyrazinamide, rifampicin, amoxicillin with clavulanic acid, erythromicin, chlorpromazine, nimesulide, and ticlopidine presented the highest risk (point relative risk > 25). Amoxicillin, metoclopramide, captopril and enalapril, furosemide, hydrochlorothiazide, fluoxetine, paroxetine, diazepam, alprazolam, lorazepam, metamizole, low-dose acetylsalicylic acid and salbutamol showed the lowest risk (point relative risk < 5).
Conclusions: This study provides a risk estimation of serious liver disease for various drugs that will be useful in its diagnosis and management, and when comparing with the drug therapeutic benefit in each indication. Some observed associations would be worth specific studies.
Comment in
- Toxicity of chronic paracetamol ingestion.
Watelet J, Laurent V, Bressenot A, Bronowicki JP, Larrey D, Peyrin-Biroulet L. Watelet J, et al. Aliment Pharmacol Ther. 2007 Dec;26(11-12):1543-4; author reply 1545-6. doi: 10.1111/j.1365-2036.2007.03503.x. Aliment Pharmacol Ther. 2007. PMID: 18039229 No abstract available.
Similar articles
- Acute and clinically relevant drug-induced liver injury: a population based case-control study.
de Abajo FJ, Montero D, Madurga M, García Rodríguez LA. de Abajo FJ, et al. Br J Clin Pharmacol. 2004 Jul;58(1):71-80. doi: 10.1111/j.1365-2125.2004.02133.x. Br J Clin Pharmacol. 2004. PMID: 15206996 Free PMC article. - Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury.
Jinjuvadia K, Kwan W, Fontana RJ. Jinjuvadia K, et al. Am J Gastroenterol. 2007 Nov;102(11):2437-43. doi: 10.1111/j.1572-0241.2007.01456.x. Epub 2007 Jul 27. Am J Gastroenterol. 2007. PMID: 17662100 - Use of amoxicillin and amoxicillin-clavulanic acid and hospitalization for acute liver injury.
Maggini M, Raschetti R, Agostinis L, Cattaruzzi C, Troncon MG, Simon G. Maggini M, et al. Ann Ist Super Sanita. 1999;35(3):429-33. Ann Ist Super Sanita. 1999. PMID: 10721209 - Drug-induced liver damage -- a three-year study of patients from one gastroenterological department.
Hartleb M, Biernat L, Kochel A. Hartleb M, et al. Med Sci Monit. 2002 Apr;8(4):CR292-6. Med Sci Monit. 2002. PMID: 11951073 Review.
Cited by
- Common Gastrointestinal Medications Implicated in Drug-Induced Liver Injury.
Garg K, Kramer J, Eswaran S. Garg K, et al. Clin Liver Dis (Hoboken). 2021 Oct 27;18(4):184-188. doi: 10.1002/cld.1110. eCollection 2021 Oct. Clin Liver Dis (Hoboken). 2021. PMID: 34745575 Free PMC article. Review. - Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident Users.
Hedenmalm K, Pacurariu A, Slattery J, Kurz X, Candore G, Flynn R. Hedenmalm K, et al. Drug Saf. 2021 Sep;44(9):973-985. doi: 10.1007/s40264-021-01087-7. Epub 2021 Jul 17. Drug Saf. 2021. PMID: 34273099 - Co-abuse of alprazolam augments the hepato-renal toxic effects of methylphenidate.
Dutt M, Dharavath RN, Kaur T, Kaur N, Chopra K, Sharma S. Dutt M, et al. Indian J Pharmacol. 2020 May-Jun;52(3):216-221. doi: 10.4103/ijp.IJP_758_19. Epub 2020 Aug 4. Indian J Pharmacol. 2020. PMID: 32874006 Free PMC article. - Dual versus single vessel normothermic ex vivo perfusion of rat liver grafts using metamizole for vasodilatation.
Claussen F, Gassner JMGV, Moosburner S, Wyrwal D, Nösser M, Tang P, Wegener L, Pohl J, Reutzel-Selke A, Arsenic R, Pratschke J, Sauer IM, Raschzok N. Claussen F, et al. PLoS One. 2020 Jul 2;15(7):e0235635. doi: 10.1371/journal.pone.0235635. eCollection 2020. PLoS One. 2020. PMID: 32614897 Free PMC article. - Drug induced liver injury: East versus West - a systematic review and meta-analysis.
Low EXS, Zheng Q, Chan E, Lim SG. Low EXS, et al. Clin Mol Hepatol. 2020 Apr;26(2):142-154. doi: 10.3350/cmh.2019.1003. Epub 2019 Dec 10. Clin Mol Hepatol. 2020. PMID: 31816676 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical